Ustekinumab: "real-world" outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease

Saved in:
Bibliographic Details
Main Authors: Hoffmann, Peter (Author) , Krisam, Johannes (Author) , Wehling, Cyrill (Author) , Klöters-Plachky, Petra (Author) , Leopold, Yvonne (Author) , Belling, Nina (Author) , Gauss, Annika (Author)
Format: Article (Journal)
Language:English
Published: Aug 21, 2019
In: World journal of gastroenterology
Year: 2019, Volume: 25, Issue: 31, Pages: 4481-4492
ISSN:2219-2840
DOI:10.3748/wjg.v25.i31.4481
Online Access:Verlag, Volltext: https://doi.org/10.3748/wjg.v25.i31.4481
Verlag, Volltext: https://www.wjgnet.com/1007-9327/full/v25/i31/4481.htm
Get full text
Author Notes:Peter Hoffmann, Johannes Krisam, Cyrill Wehling, Petra Kloeters-Plachky, Yvonne Leopold, Nina Belling, Annika Gauss
Description
Summary:Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
Item Description:Gesehen am 16.11.2019
Physical Description:Online Resource
ISSN:2219-2840
DOI:10.3748/wjg.v25.i31.4481